A LOCAL court has denied Pfizer Inc.'s bid to stop the sale of a generic version of anti-hypertensive drug Variant manufactured by Philippine drug-maker United Laboratories Inc. (Unilab). In a statement, Pfizer said it would ask the court to reconsider its ruling on the generic version of Atorvastatin Calcium. Pfizer and co-plaintiff Warner Lambert Co. LLC had filed a patent infringement case against Unilab in October last year. Pfizer said it owns the Philippine patent of Atorvastatin Calcium, adding this patent would expire in 2012. The drug is sold by the company under the brand name Lipitor. Unilab and its sister company Therapharma Inc. also in October last year had released Avamax, a generic version of Atorvastatin. Unilab had also filed an invalidation case against Pfizer's Atorvastatin patent before the Intellectual Property Office of the Philippines in July last year, but this case is still pending.
No comments:
Post a Comment